• Service
  • Resources
    • Webinars
    • Upcoming Events
    • Documents Download
    • FAQ
    • NMPA Approval Report
  • News
  • CER
  • About
Subscribe

Our Services

Strategy Consulting

  • Market Entry Strategy
  • Regulatory Strategy
  • Clinical Strategy
  • China Localization Strategy
  • Hainan Urgent Use Pathway
  • Innovation Pathway
  • Fast Track Pathway
  • Digital Health Consulting

Registration Affairs

  • Pre-market Registration
  • Modification Registration
  • Renewal Registration
  • Request for Classification
  • Legal Agent Representation
  • NMPA Expert Panel Meeting
  • NMPA Supplemental Notice

Quality Assurance

  • Postmarket Surveillance Compliance (IFU, Label, GSP)
  • Adverse Event Reporting
  • Recall Handling
  • Periodic Risk Evaluation Report
  • Annual QMS Self-Inspection Report
  • NMPA Inspections & Mock-Audit
  • QMS Establishment/Audit/Remediation
  • QA Gap Analysis
  • Factory Audit
  • Unique Device Identifier

Device Testing

  • China Local Type Testing
  • Device Modification Compliance Testing
  • Biocompatibility Testing
  • EMC Testing

Clinical Research Organization (CRO)

  • Clinical Trials/Research
  • Real-World Study
  • China CER & MDR CER
  • Clinical Evaluation Feasibility Assessment

Customized Training

  • China Regulatory Training
  • China QMS Training
  • China GCP Training
  • China Localization Training
  • Periodic Regulatory Updates Training

Other Services

  • Translation
  • Patent & Trademark
  • Distributor Evaluation & Audit
  • KOL Interview/Consultation
  • Investment
  • Global regulatory services
  • Service
  • Resources
    • Resources
    • Webinars
    • Upcoming Events
    • Documents Download
    • FAQ
    • NMPA Approval Report
  • News
  • About
  • CER
  • Subscribe
  • CN
  • US
  • Home
  • News
  • QMS/PMS

News


  • Moments
  • Regulations & Guidelines
  • Fast Track Update
  • QMS/PMS
  • Other News
  • NMPA Monthly Newsletter
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021

NMPA Notice On The Publication Of Guidelines For Quality Management System Audit Of Medical Device Registration

2022-10-23

In order to do a good job of quality management system audit under medical device MAH (Market Authorization Holder) system…

NMPA Notice On The Filing Examination Requirements For Medical Device Registration

2022-10-09

On August 31, NMPA released a notice on the issue of Filing Examination Requirements for Medical Device Registration…

China’s First Domestically Produced Proton Therapy System Gained Approval For Marketing

2022-10-08

On Sep 26, 2022, NMPA approved the registration application of the innovative device “Proton Therapy System” produced by…

China NMPA Newsletter – August 2022

2022-09-30

Featured Articles NMPA New Approvals In August 2022 In August 2022, NMPA approved 210 medical devices, including 25…

NMPA New Approvals In August 2022

2022-09-22

In August 2022, NMPA approved 210 medical devices, including 25 Class III imported products, 22 Class II imported…

Guidelines On The Registration Of Registered Class II Medical Devices Moving Into Guangdong Province

2022-09-17

In order to continuously optimize the business environment and promote the high-quality development of the medical device industry…

China NMPA Newsletter – July 2022

2022-08-30

Featured Articles NMPA New Approvals In July 2022 In July 2022, NMPA approved 197 medical devices, including 20…

NMPA New Approvals In July 2022

2022-08-23

In July 2022, NMPA approved 197 medical devices, including 20 Class III imported products, 22 Class II imported…

NMPA Notice On Matters Related To The Filing Of Class I Medical Devices

2022-08-19

In order to do a good job in the filing of Class I medical devices, the NMPA issued…

NMPA Collecting Public Comments On The Drafts Of Terms And Definitions For Medical Device Clinical Evaluation And IVD Clinical Performance Studies

2022-08-16

On August 10, 2022, NMPA issued a notice to collect public comments to establish industry standards of MD…

NMPA Notice On Special Review Procedures Of Innovative Medical Devices

2022-08-05

NMPA published Special Review Procedures Of Innovative Medical Devices on November 5, 2018. The implementation of this procedure…

China Supporting Hong Kong And Macao Medical Device Registrants To Produce Medical Devices In 9 Cities Of The Greater Bay Area

2022-08-04

To promote the reform of the medical device registrant system (Market Authorization Holder, MAH for short) in the…
« Prev...24...89101112...1618...Next »
Twitter Linkedin
United States
Email: info@bradyknowsmedical.com
Phone: +86 18600392020
China
Beijing Office: Room 1501-1502, East Ocean Centre, No. 24 A, Jianguomenwai Avenue, Chaoyang District, Beijing, China
Shanghai Office: Lingang New Zone, China (Shanghai) Pilot Free Trade Zone
Hainan Office: Boao Lecheng pilot zone of international medical tourism, Qionghai City, Hainan Province
Email: info@bradyknowsmedical.com
Phone: +86 18600392020 +86 10 65155991

©2025 Bradynuoen Beijing PharmTech Co Ltd All Rights Reserved.

京ICP备15042665号-7